P&B Labs Reductin 200 tabs (10 mg/tab)

Sibutramīns

Sibutramine tablets are designed to assist individuals with obesity in weight loss when combined with a low-calorie diet. Most users experience significant weight loss within the first six months of treatment alongside proper diet and exercise.

Marketed by Abbott Laboratories, Sibutramīns is found under the brand names Meridia® in the USA and Reductil® in Europe. Initially, this pharmaceutical agent is sold under patent protection, allowing only the developing company to market it. However, once the patent expires, generic versions of Sibutramīns can be produced, offering the same effectiveness at a reduced cost.

Generic medications must replicate the original formulation’s active ingredients, ensuring equivalent dose, strength, route of administration, safety, efficacy, and intended use. Availability of generics generally follows the expiration of patent protections, resulting in competitive pricing for both the original and generic drugs.

Dozēšana

Recommended dosage is typically between 10-20 mg per day, subject to variation.